A 2-arm, 6-month, nonrandomized controlled pilot trial was conducted to test the initial effectiveness of the Life Enhancing Alcohol-management Program (LEAP) as an adjunct to Housing First (HF; e.g., permanent supportive housing) on alcohol and quality-of-life (QoL) outcomes. The LEAP entails resident-driven leadership opportunities, meaningful activities, and pathways to recovery aimed at reducing alcohol-related harm and improving QoL. Data analyses were conducted to test between- and within-subjects effects of the LEAP on self-reported alcohol and QoL outcomes among HF residents. At the 6-month follow up, between groups analysis revealed nonsignificant findings for alcohol quantity or alcohol-related harm (ps > 0.06); however, LEAP participants reported significantly more engagement in meaningful activities than control participants (p < .001), and within-subjects analyses indicated that high levels of LEAP programming engagement predicted significant reductions in alcohol quantity and alcohol-related harm (ps < 0.01). The LEAP was associated with increased engagement in meaningful activities, and greater involvement in the LEAP programming was associated with reduced alcohol use and alcohol-related harm. Planning is underway for a future, large-scale randomized controlled trial to establish the efficacy of this approach, its generalizability across HF programs, and potential mechanisms of action.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9970685 | PMC |
http://dx.doi.org/10.1002/jcop.22291 | DOI Listing |
Subst Use Addctn J
November 2024
Program for Addiction Research, Clinical Care, Knowledge and Advocacy (PARCKA) and Greater Intermountain Node (GIN) of the NIDA Clinical Trials Network, Division of Epidemiology, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT, USA.
Background: The U.S. Preventive Services Task Force recommends that all healthcare providers be trained to screen for misuse and/or opioid use disorder.
View Article and Find Full Text PDFJ Addict Med
August 2024
From the Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine, 3131 Harvey Avenue, Cincinnati, OH (TJW, FK, DL); Center for Addiction Research, University of Cincinnati College of Medicine, Cincinnati, OH (TJW, FK, DL); Depart of Psychiatry, Harvard Medical School, Boston, MA (SFG); McLean Hospital, Division of Women's Mental Health and Division of Alcohol, Drugs and Addiction, Belmont, MA (SFG); Department of Obstetrics, Gynecology, and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, PA (EEK); Magee-Womens Research Institute, University of Pittsburgh, Pittsburgh, PA (EEK); Department of Psychiatry and Behavioral Sciences and Department of Pharmacology, Vanderbilt University Medical Center, Nashville, TN (PRM); Program for Addiction Research, Clinical Care, Knowledge and Advocacy (PARCKA), Division of Epidemiology, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT (AJG); Informatics, Decision-Enhancement, and Analytic Sciences (IDEAS) Center, VA Salt Lake City Health Care System, Salt Lake City, UT (AJG); Department of Family and Community Health, Marshall University Joan C. Edwards School of Medicine, Huntington, WV (THD); Department of Pediatrics, One Boston Medical Center Place, Boston Medical Center, Boston, MA (EMW); University of Pittsburgh School of Medicine, Department of Psychiatry, Western Psychiatric Hospital, University of Pittsburgh Medical, Pittsburgh, PA (AD, XX); Department of Family Medicine Oregon Health Sciences University Portland, OR (KP); Department of Population Health Sciences, Joan & Sanford I. Weill Medical College of Cornell University, New York, NY (AJ); and Departments of Behavioral Science and Psychiatry, Center on Drug and Alcohol Research University of Kentucky College of Medicine, Lexington, KY (MRL).
Objectives: Trauma screening is recommended for pregnant persons with opioid use disorder (OUD), but there is limited literature on screening results from buprenorphine treatment. This study's objectives were to 1) describe the types, and severity, of traumatic events reported and 2) evaluate the associations between trauma and health-related quality of life (HRQoL).
Methods: Baseline data from an ongoing trial were analyzed.
BMJ Open
July 2024
School of Medicine, University of Utah Health, Salt Lake City, Utah, USA.
Introduction: Many individuals receiving outpatient physical therapy have musculoskeletal pain and up to one-third use prescription opioids. The impact of physical therapist-led mindfulness-based interventions integrated with evidence-based physical therapy (I-EPT) to manage patients with chronic musculoskeletal pain and long-term opioid treatment has not been elucidated. This project evaluates the feasibility of conducting a cluster randomised trial to test the effectiveness of I-EPT.
View Article and Find Full Text PDFJ Phys Ther Educ
December 2024
John Magel is the research associate professor in the Department of Physical Therapy and Athletic Training at the University of Utah, 520 Wakara Way, Salt Lake City, UT 84108 ( ). Please address all correspondence to John Magel.
Introduction: Musculoskeletal pain and opioid misuse frequently co-occur.
Review Of The Literature: The US Preventive Services Task Force calls for all health care providers to be trained to screen for misuse and/or opioid use disorder. The purpose of this study was to develop and implement an opioid misuse training program that could be used by physical therapists.
Subst Use Addctn J
April 2024
Center for Health Economics of Treatment Interventions for Substance Use Disorder, HCV, and HIV (CHERISH), Department of Population Health Sciences, Weill Cornell Medicine, New York, NY, USA.
The Addiction Health Services Research (AHSR) Conference has been held since 2002. This Conference brings together researchers, graduate students, policymakers, and treatment providers to focus improving the organization, distribution, and financing of healthcare resources for prevention/care of SUD. The AHSR 2023 Conference took place in New York City, October 18-20, and was hosted by the Center for Health Economics of Treatment Interventions for Substance Use Disorder, HCV, and HIV (CHERISH; cherishresearch.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!